|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Genomic Health Wins Medicare Coverage for High-Priced Colon Cancer Test
|
Luke Timmerman |
09/30/11 |
San Francisco
|
|
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus
|
Luke Timmerman |
08/08/11 |
National
|
|
Dendreon Takes Huge Hit, Stock Tanks 60% on Sales Shortfall
|
Luke Timmerman |
08/03/11 |
Seattle
|
|
SeaGen Preserves Science Culture, Dendreon Sways Medicare, NanoString’s Financing, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/07/11 |
Seattle
|
|
Dendreon Wins Full Reimbursement From Medicare for $93K Prostate Cancer Drug
|
Luke Timmerman |
03/30/11 |
Seattle
|
|
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/18/10 |
Seattle
|
|
Dendreon Passes Medicare Panel’s Questions About Provenge Effectiveness
|
Luke Timmerman |
11/17/10 |
Seattle
|
|
Dendreon Prepares to Take Some Heat in the Other Washington Over Cancer Drug Prices
|
Luke Timmerman |
11/16/10 |
Seattle
|
|
Dendreon’s Provenge Launch Story Enters Second Chapter, With Today’s Earnings Call
|
Luke Timmerman |
11/03/10 |
Seattle
|
|
Athenahealth Taps Sermo Docs for Opinions on Electronic Health Records
|
Ryan McBride |
03/01/10 |
Boston
|
|
eClinicalWorks Tops $100M Sales as Doctors Move from Paper to Pixel Records
|
Ryan McBride |
02/05/10 |
Boston
|
|
IkaSystems Gets Capital Infusions from Essex Woodlands Health Ventures and Providence Equity Partners
|
Ryan McBride |
01/19/10 |
Boston
|
|
Ekos, Enduring Tough Year for Devices, Sticks With Goal to Break Even Next Year
|
Luke Timmerman |
11/30/09 |
Seattle
|
|
How Did Calypso Raise $50M? The Story Behind Seattle’s Biggest VC Deal of 2009
|
Luke Timmerman |
09/18/09 |
Seattle
|
|
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 2
|
Luke Timmerman |
07/28/09 |
Seattle
|
|
Amag Pharmaceuticals Wins FDA Approval to Sell Iron Deficiency Drug
|
Luke Timmerman |
06/30/09 |
Boston
|
|
Genzyme Enters Seattle Hub, Oncothyreon Bets on Cancer Drugs, Pathway Nabs $40M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/02/09 |
Seattle
|
|
Riding a Cancer Diagnostics Wave, Genoptix Sees Boom Continuing in 2009
|
Luke Timmerman |
04/01/09 |
San Diego
|
|
Calypso Gets Florida Medicare Unit to Pay for “GPS for the Body” for Prostate Cancer
|
Luke Timmerman |
03/27/09 |
Seattle
|
|
Congress Overrides Bush Veto on Medicare Bill, Cell Therapeutics’ Zevalin Reimbursement Survives
|
Luke Timmerman |
07/16/08 |
Seattle
|
|
Cell Therapeutics Gets a Win on Capitol Hill, Zevalin Reimbursement To Remain Same
|
Luke Timmerman |
07/09/08 |
Seattle
|
|
Calypso Medical’s “GPS For the Body” Gaining Ground With Radiation Doctors
|
Luke Timmerman |
06/25/08 |
Seattle
|
|
Abiomed Wins FDA Approval of Heart Pump
|
Luke Timmerman |
06/02/08 |
Boston
|
|
Medicare Will Cover Abiomed Heart
|
Wade Roush |
05/02/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.